ALPMY:OTCMKTS
Astellas Pharma ADR Representing 1 Ord Shs
$14.35
arrow_upward
+1.06%(+0.15) 1D
Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALPMY...
Open
$14.23
High
$14.37
Low
$14.17
Mkt. cap
4.07T
Avg. vol.
100.36K
Volume
122.21K
52-wk high
$17.35
52-wk low
$10.03
Beta
0.13
Shares outstanding
1.81B
No. of employees
14K
Open
$14.23
High
$14.37
Low
$14.17
Mkt. cap
4.07T
Avg. vol.
100.36K
Volume
122.21K
52-wk high
$17.35
52-wk low
$10.03
Beta
0.13
Shares outstanding
1.81B
No. of employees
14K
News stories
From web sources and news partners
Traders Union
·
18 minutes ago
S&P 500 to report Q3 earnings growth above 35 percent, Christophe Barraud notes
The Motley Fool
·
17 minutes ago
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
NTD News
·
28 minutes ago
Wall Street Review: S&P 500 Closes Near All-Time High
ChartMill
·
19 hours ago
Friday's session: top gainers and losers in the dow jones index
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma ADR Representing 1 Ord Shs
CEONaoki Okamura
Employees14.1K
FoundedApr 1, 2005
HeadquartersChuo City, Tokyo, Japan
SectorPharmaceutical industry
Websiteastellas.com